GO TO: Recent Comment Letters
ALL |
All 10-K/Qs
Large
Mid
Small
Micro
|
Earnings Release
Proxy
|
SORT BY :
Most Recent
Company Name
| Company | Time | Size | View | Financials | Document | SEC | Period | Revenue MRQ | Assets | EPS Diluted | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | 8/14/2026 4:55:21 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2026 ending: 6/30/2026 | Rev: $1,493,788 | Assets $142,255,198 | EPS -$0.34 | |
| Citius Pharmaceuticals, Inc. (CTXR) | 8/14/2026 4:40:18 PM | View | Financials | Earnings | SEC | 3Q 2026 | Rev $1,493,788 | Assets $142,255,198 | EPS -$0.34 | Export Earnings Model | |
| Citius Pharmaceuticals, Inc. (CTXR) | 5/15/2026 4:45:15 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2026 ending: 3/31/2026 | Rev: $1,667,298 | Assets $132,540,579 | EPS -$0.95 | |
| Citius Pharmaceuticals, Inc. (CTXR) | 5/15/2026 4:43:43 PM | View | Financials | Earnings | SEC | 2Q 2026 | Rev $1,667,298 | Assets $132,540,579 | EPS -$0.95 | Export Earnings Model | |
| Citius Pharmaceuticals, Inc. (CTXR) | 2/24/2026 8:02:06 AM | View | Proxy | SEC | Y 2025 | ||||||
| Citius Pharmaceuticals, Inc. (CTXR) | 2/13/2026 8:31:21 AM | View | Financials | Earnings | SEC | 1Q 2026 | Rev $3,944,111 | Assets $140,391,730 | EPS -$0.38 | Export Earnings Model | |
| Citius Pharmaceuticals, Inc. (CTXR) | 2/13/2026 8:13:26 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2026 ending: 12/31/2025 | Rev: $3,944,111 | Assets $140,391,730 | EPS -$0.38 | |
| Citius Pharmaceuticals, Inc. (CTXR) | 1/28/2026 4:45:26 PM | Micro | View | Financials | 10-K/A | SEC | Y 2025 ending: 9/30/2025 | Assets $130,938,025 | EPS -$3.38 | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 12/23/2025 4:50:12 PM | View | Financials | Earnings | SEC | Y 2025 | Assets $130,938,025 | EPS -$0.11 | Export Earnings Model | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 12/23/2025 4:34:10 PM | Micro | View | Financials | 10-K | SEC | Y 2025 ending: 9/30/2025 | Assets $130,938,025 | EPS -$3.38 | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 8/12/2025 4:53:10 PM | View | Financials | Earnings | SEC | 3Q 2025 | Assets $127,676,859 | EPS -$0.80 | Export Earnings Model | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 8/12/2025 4:45:05 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2025 ending: 6/30/2025 | Assets $127,676,859 | EPS -$0.80 | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 5/14/2025 4:43:56 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2025 ending: 3/31/2025 | Assets $121,481,411 | EPS -$1.27 | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 5/14/2025 4:32:57 PM | View | Financials | Earnings | SEC | 2Q 2025 | Assets $121,481,411 | EPS -$1.27 | Export Earnings Model | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 4/28/2025 7:31:23 AM | View | Proxy | SEC | Y 2024 | ||||||
| Citius Pharmaceuticals, Inc. (CTXR) | 2/14/2025 4:48:46 PM | View | Financials | Earnings | SEC | 1Q 2025 | Assets $120,703,457 | EPS -$1.30 | Export Earnings Model | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 2/14/2025 4:42:13 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2025 ending: 12/31/2024 | Assets $120,703,457 | EPS -$1.30 | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 1/27/2025 4:22:29 PM | Micro | View | Financials | 10-K/A | SEC | Y 2024 ending: 9/30/2024 | Assets $116,651,751 | EPS -$5.97 | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 1/27/2025 4:06:32 PM | View | Proxy | SEC | Y 2024 | ||||||
| Citius Pharmaceuticals, Inc. (CTXR) | 12/27/2024 5:15:09 PM | Micro | View | Financials | 10-K | SEC | Y 2024 ending: 9/30/2024 | Assets $116,651,751 | EPS -$5.97 | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 12/27/2024 5:10:45 PM | View | Financials | Earnings | SEC | Y 2024 | Assets $116,651,751 | Export Earnings Model | |||
| Citius Pharmaceuticals, Inc. (CTXR) | 8/12/2024 5:26:12 PM | View | Financials | Earnings | SEC | 3Q 2024 | Assets $97,090,579 | Export Earnings Model | |||
| Citius Pharmaceuticals, Inc. (CTXR) | 8/12/2024 5:06:11 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2024 ending: 6/30/2024 | Assets $97,090,579 | |||
| Citius Pharmaceuticals, Inc. (CTXR) | 5/14/2024 4:27:43 PM | View | Financials | Earnings | SEC | 2Q 2024 | Assets $90,711,369 | Export Earnings Model | |||
| Citius Pharmaceuticals, Inc. (CTXR) | 5/14/2024 4:17:56 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2024 ending: 3/31/2024 | Assets $90,711,369 | |||
| Citius Pharmaceuticals, Inc. (CTXR) | 2/15/2024 8:46:36 AM | View | Financials | Earnings | SEC | 1Q 2024 | Assets $97,399,822 | Export Earnings Model | |||
| Citius Pharmaceuticals, Inc. (CTXR) | 2/14/2024 4:58:25 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2024 ending: 12/31/2023 | Assets $97,399,822 | |||
| Citius Pharmaceuticals, Inc. (CTXR) | 1/26/2024 4:07:59 PM | View | Proxy | SEC | Y 2023 | ||||||
| Citius Pharmaceuticals, Inc. (CTXR) | 1/2/2024 4:05:11 PM | View | Financials | Earnings | SEC | Y 2023 | Assets $103,611,150 | Export Earnings Model | |||
| Citius Pharmaceuticals, Inc. (CTXR) | 12/29/2023 4:16:47 PM | Micro | View | Financials | 10-K | SEC | Y 2023 ending: 9/30/2023 | Assets $103,611,150 | |||
| Citius Pharmaceuticals, Inc. (CTXR) | 8/15/2023 9:26:30 AM | View | Financials | Earnings | SEC | 3Q 2023 | Assets $110,404,835 | EPS -$0.06 | Export Earnings Model | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 8/14/2023 4:17:57 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2023 ending: 6/30/2023 | Assets $110,404,835 | EPS -$0.06 | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 5/12/2023 4:46:24 PM | View | Financials | Earnings | SEC | 2Q 2023 | Assets $104,240,826 | EPS -$0.07 | Export Earnings Model | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 5/12/2023 4:33:07 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2023 ending: 3/31/2023 | Assets $104,240,826 | EPS -$0.07 | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 2/10/2023 4:46:29 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2023 ending: 12/31/2022 | Assets $111,705,221 | EPS -$0.02 | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 2/10/2023 4:37:01 PM | View | Financials | Earnings | SEC | 1Q 2023 | Assets $111,705,221 | EPS -$0.02 | Export Earnings Model | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 12/22/2022 4:46:33 PM | Micro | View | Financials | 10-K | SEC | Y 2022 ending: 9/30/2022 | Assets $113,999,302 | EPS -$0.23 | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 12/22/2022 4:42:12 PM | View | Financials | Earnings | SEC | Y 2022 | Assets $113,999,302 | EPS -$0.05 | Export Earnings Model | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 12/22/2022 4:36:46 PM | View | Proxy | SEC | Y 2022 | ||||||
| Citius Pharmaceuticals, Inc. (CTXR) | 8/11/2022 4:47:05 PM | View | Financials | Earnings | SEC | 3Q 2022 | Assets $120,315,795 | EPS -$0.06 | Export Earnings Model | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 8/11/2022 4:36:02 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2022 ending: 6/30/2022 | Assets $120,315,795 | EPS -$0.06 | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 5/12/2022 4:49:15 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2022 ending: 3/31/2022 | Assets $127,785,970 | |||
| Citius Pharmaceuticals, Inc. (CTXR) | 5/12/2022 4:46:29 PM | View | Financials | Earnings | SEC | 2Q 2022 | Assets $127,785,970 | Export Earnings Model | |||
| Citius Pharmaceuticals, Inc. (CTXR) | 2/10/2022 4:37:32 PM | View | Financials | Earnings | SEC | 1Q 2022 | Assets $137,516,076 | EPS -$0.06 | Export Earnings Model | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 2/10/2022 4:20:54 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2022 ending: 12/31/2021 | Assets $137,516,076 | EPS -$0.06 | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 12/20/2021 4:17:07 PM | View | Proxy | SEC | Y 2021 | ||||||
| Citius Pharmaceuticals, Inc. (CTXR) | 12/15/2021 4:40:37 PM | Micro | View | Financials | 10-K | SEC | Y 2021 ending: 9/30/2021 | Assets $142,429,059 | EPS -$0.23 | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 12/15/2021 4:31:59 PM | View | Financials | Earnings | SEC | Y 2021 | Assets $142,429,059 | EPS -$0.03 | Export Earnings Model | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 8/12/2021 4:59:43 PM | View | Financials | Earnings | SEC | 3Q 2021 | Assets $146,592,848 | EPS -$0.05 | Export Earnings Model | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 8/12/2021 4:55:26 PM | Small | View | Financials | 10-Q | SEC | 3Q 2021 ending: 6/30/2021 | Assets $146,592,848 | EPS -$0.05 | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 5/13/2021 8:21:38 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2021 ending: 3/31/2021 | Assets $134,666,413 | |||
| Citius Pharmaceuticals, Inc. (CTXR) | 5/13/2021 8:01:32 AM | View | Financials | Earnings | SEC | 2Q 2021 | Assets $134,666,413 | Export Earnings Model | |||
| Citius Pharmaceuticals, Inc. (CTXR) | 4/12/2021 4:07:26 PM | View | Proxy | SEC | Y 2020 | ||||||
| Citius Pharmaceuticals, Inc. (CTXR) | 2/11/2021 4:14:14 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2021 ending: 12/31/2020 | Assets $35,311,781 | EPS -$0.15 | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 12/21/2020 4:07:06 PM | View | Proxy | SEC | Y 2020 | ||||||
| Citius Pharmaceuticals, Inc. (CTXR) | 12/16/2020 4:14:33 PM | Micro | View | Financials | 10-K | SEC | Y 2020 ending: 9/30/2020 | Assets $43,773,655 | EPS -$0.45 | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 8/14/2020 5:25:36 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2020 ending: 6/30/2020 | Assets $38,399,718 | EPS -$0.11 | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 5/14/2020 4:35:47 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2020 ending: 3/31/2020 | Assets $26,492,738 | EPS -$0.13 | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 2/13/2020 4:25:10 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2020 ending: 12/31/2019 | Assets $24,982,854 | EPS -$0.15 | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 12/20/2019 4:35:19 PM | View | Proxy | SEC | Y 2019 | ||||||
| Citius Pharmaceuticals, Inc. (CTXR) | 12/16/2019 4:50:49 PM | Micro | View | Financials | 10-K | SEC | Y 2019 ending: 9/30/2019 | Assets $36,746,394 | EPS -$0.77 | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 8/14/2019 4:23:23 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2019 ending: 6/30/2019 | Assets $25,544,947 | EPS -$0.20 | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 5/15/2019 5:05:32 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2019 ending: 3/31/2019 | Assets $24,235,696 | EPS -$0.20 | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 2/14/2019 6:25:11 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2019 ending: 12/31/2018 | Assets $28,078,307 | EPS -$0.22 | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 12/20/2018 4:07:56 PM | View | Proxy | SEC | Y 2018 | ||||||
| Citius Pharmaceuticals, Inc. (CTXR) | 12/13/2018 8:41:55 AM | Micro | View | Financials | 10-K | SEC | Y 2018 ending: 9/30/2018 | Assets $31,050,524 | EPS -$1.17 | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 8/14/2018 5:26:13 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2018 ending: 6/30/2018 | Assets $23,825,614 | EPS -$0.19 | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 5/11/2018 4:14:11 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2018 ending: 3/31/2018 | Assets $26,063,575 | EPS -$0.44 | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 2/14/2018 6:37:15 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2018 ending: 12/31/2017 | Assets $28,473,071 | EPS -$0.38 | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 12/13/2017 4:53:40 PM | Micro | View | Financials | 10-K | SEC | Y 2017 ending: 9/30/2017 | Assets $24,416,553 | EPS -$1.89 | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 12/13/2017 4:44:03 PM | View | Proxy | SEC | Y 2017 | ||||||
| Citius Pharmaceuticals, Inc. (CTXR) | 8/14/2017 5:05:25 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2017 ending: 6/30/2017 | Assets $21,567,225 | EPS -$0.48 | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 5/15/2017 5:54:41 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2017 ending: 3/31/2017 | Assets $21,334,608 | EPS -$0.55 | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 2/14/2017 5:23:21 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2017 ending: 12/31/2016 | Assets $21,482,323 | EPS -$0.44 | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 12/23/2016 5:01:13 PM | Micro | View | Financials | 10-K | SEC | Y 2016 ending: 9/30/2016 | Assets $21,950,341 | EPS -$2.29 | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 8/15/2016 4:16:36 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2016 ending: 6/30/2016 | Rev: $782 +162.4% | Assets $23,013,945 | EPS -$0.75 | |
| Citius Pharmaceuticals, Inc. (CTXR) | 8/11/2016 5:16:39 PM | View | Proxy | SEC | Y 2015 | ||||||
| Citius Pharmaceuticals, Inc. (CTXR) | 5/20/2016 8:45:35 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2016 ending: 3/31/2016 | Rev: $3 -99.3% | Assets $24,779,028 | EPS -$0.35 | |
| Citius Pharmaceuticals, Inc. (CTXR) | 2/12/2016 11:31:39 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2016 ending: 12/31/2015 | Rev: $15 -99.3% | Assets $346,890 | EPS -$0.04 | |
| Citius Pharmaceuticals, Inc. (CTXR) | 12/14/2015 4:09:04 PM | Micro | View | Financials | 10-K | SEC | Y 2015 ending: 9/30/2015 | Assets $741,538 | EPS -$1.37 | ||
| Citius Pharmaceuticals, Inc. (CTXR) | 8/13/2015 5:30:00 AM | Micro | View | Financials | 10-Q | SEC | 3Q 2015 ending: 6/30/2015 | Rev: $298 | Assets $962,316 | EPS -$0.03 | |
| Citius Pharmaceuticals, Inc. (CTXR) | 5/13/2015 2:22:46 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2015 ending: 3/31/2015 | Rev: $447 | Assets $765,756 | EPS -$0.01 | |
| Citius Pharmaceuticals, Inc. (CTXR) | 2/17/2015 4:21:35 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2015 ending: 12/31/2014 | Rev: $2,208 | Assets $822,638 | EPS -$0.03 | |
| Citius Pharmaceuticals, Inc. (CTXR) | 12/29/2014 3:51:46 PM | Micro | View | Financials | 10-KT | SEC | 3Q 2014 ending: 9/30/2014 | ||||
| Trail One, Inc. (CTXR) | 8/14/2014 12:27:05 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2014 ending: 6/30/2014 | ||||
| Trail One, Inc. (CTXR) | 5/15/2014 11:14:45 AM | Micro | View | Financials | 10-Q | SEC | 2Q 2014 ending: 3/31/2014 | ||||
| Trail One, Inc. (CTXR) | 2/19/2014 4:18:03 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2014 ending: 12/31/2013 | Assets $107,965 | |||
| Trail One, Inc. (CTXR) | 2/6/2014 2:53:59 PM | Micro | View | Financials | 10-K | SEC | Y 2013 ending: 9/30/2013 | ||||
| Trail One, Inc. (CTXR) | 9/18/2013 3:07:58 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2013 ending: 6/30/2013 | Assets $27 | |||
| Trail One, Inc. (CTXR) | 5/13/2013 3:13:16 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2013 ending: 3/31/2013 | Assets $63 | |||
| Trail One, Inc. (CTXR) | 2/8/2013 11:53:09 AM | Micro | View | Financials | 10-Q | SEC | 1Q 2013 ending: 12/31/2012 | Assets $99 | |||
| Trail One, Inc. (CTXR) | 1/15/2013 1:09:25 PM | Micro | View | Financials | 10-K | SEC | Y 2012 ending: 9/30/2012 | Assets $135 | |||
| Trail One, Inc. (CTXR) | 8/17/2012 5:02:33 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2012 ending: 6/30/2012 | Assets $171 | |||
| Trail One, Inc. (CTXR) | 5/11/2012 1:32:47 PM | Micro | View | Financials | 10-Q | SEC | 2Q 2012 ending: 3/31/2012 | Assets $17 | |||
| Trail One, Inc. (CTXR) | 2/14/2012 12:26:03 PM | Micro | View | Financials | 10-Q | SEC | 1Q 2012 ending: 12/31/2011 | Assets $216 | |||
| Trail One, Inc. (CTXR) | 1/13/2012 11:45:15 AM | Micro | View | Financials | 10-K | SEC | Y 2011 ending: 9/30/2011 | Assets $212 | |||
| Trail One, Inc. (CTXR) | 8/26/2011 12:16:41 PM | Micro | View | Financials | 10-Q | SEC | 3Q 2011 ending: 6/30/2011 |